Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Midazolam for Sedation in Elderly Orthopedic Surgery
NCT07113483Phase 3Recruiting
- Sponsor
- Romanian Society for Enteral and Parenteral Nutrition
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of remimazolam in orthopedic injuries (4 arms), sponsored by Romanian Society for Enteral and Parenteral Nutrition. Primary endpoint: Confusion Assessment Method Score at 72 hours. Started Oct 2025; status: recruiting.
02
Drugs
remimazolam
03
Conditions
orthopedic injuries
Beyond the preview
Go deeper on NCT07113483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113483.